VREOD (Vireo Growth) Shareholder Yield % : -35.73% (As of Mar. 2026)


VREOD Vireo Growth Inc VREOD
52 GF Score
Price $9.99
GF Value $9.09
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Vireo Growth Shareholder Yield %?

Vireo Growth VREOD -0.15% 52 Shareholder Yield % is -35.73% as of Mar. 2026. GuruFocus rates VREOD with a GF Score™ of 52/100 and a GF Value™ of $9.09 (Fairly Valued). The stock has 6 warning signs investors should review. Among 972 Drug Manufacturers companies, Vireo Growth ranks worse than 94.24% on this metric.

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return. As of today, Vireo Growth's Shareholder Yield % was -35.73%.


Vireo Growth  (OTCPK:VREOD) Shareholder Yield % Explanation

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."

Shareholder Yield % is calculated by three components: Dividend Yield %, Buyback Yield %, and Net Debt Paydown Yield %.

Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.

Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.


Vireo Growth Shareholder Yield % Related Terms


Vireo Growth Shareholder Yield % Historical Data

* Premium members only.

The historical data trend for Vireo Growth's Shareholder Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vireo Growth Shareholder Yield % Chart

Vireo Growth Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shareholder Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.06 -112.75 155.49 -45.94 -15.97

Vireo Growth Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shareholder Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.78 -5.93 -8.83 -15.97 -42.46

VREOD vs ZTS: Shareholder Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vireo Growth's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vireo Growth Shareholder Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vireo Growth's Shareholder Yield % distribution charts can be found below:

* The bar in red indicates where Vireo Growth's Shareholder Yield % falls into.


VREOD
52GF Score
Vireo Growth Inc VREOD
Shareholder Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vireo Growth Shareholder Yield % Calculation

Vireo Growth's Shareholder Yield % for the quarter that ended in Mar. 2026 is calculated as:

Shareholder Yield %=Dividend Yield %+Buyback Yield %+Net Debt Paydown Yield %
=0.00 %+0.00 %+-44.2 %
=-44.2 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

Frequently Asked Questions Learn more about Shareholder Yield % →
What does a Shareholder Yield % of -35.73% mean?
Vireo Growth (VREOD) has a Shareholder Yield % of -35.73% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Vireo Growth and its competitors. According to the industry distribution chart, Vireo Growth ranks #916 out of 972 companies in the Drug Manufacturers industry, placing it in the top 94.2%.
Is Vireo Growth's Shareholder Yield % too high?
Vireo Growth's current Shareholder Yield % is -35.73%. Based on the distribution chart, Vireo Growth ranks #916 out of 972 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Vireo Growth has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Vireo Growth's Shareholder Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Vireo Growth ranks #916 out of 972 companies for Shareholder Yield %. This places Vireo Growth in the lower half of its industry. The industry median Shareholder Yield % is 0.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Drug Manufacturers company?
The median Shareholder Yield % among Drug Manufacturers companies is 0.30, based on 972 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Vireo Growth and its competitors. For the Drug Manufacturers industry, the median Shareholder Yield % is 0.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vireo Growth's current Shareholder Yield % is -35.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vireo Growth stock overvalued right now?
Based on GuruFocus' analysis, Vireo Growth (VREOD) is currently considered Fairly Valued. The stock's GF Value™ is $9.09, compared to a current price of $9.99 — trading 9.8% above its estimated fair value. The current Shareholder Yield % is -35.73%. Vireo Growth's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Vireo Growth (VREOD), the current Shareholder Yield % is -35.73% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vireo Growth (VREOD) Overvalued in 2026?

Based on GuruFocus' analysis, Vireo Growth stock appears to be overvalued. The current stock price of $9.99 is trading 9.8% above its estimated GF Value™ of $9.09. GuruFocus considers Vireo Growth to be Fairly Valued.

Key valuation signals for VREOD:

  • Shareholder Yield %: -35.73%
  • GF Value™: $9.09 vs. price of $9.99 (9.8% above fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the VREOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vireo Growth Business Description

Other Exchanges K95:GermanyVREO:Canada
Address 207 South 9th Street, Minneapolis, Minneapolis, MN, USA, 55402
Vireo Growth Incis a cannabis company whose mission is to provide safe access, quality products and value to its customers while supporting its local communities through active participation and restorative justice programs. The Company is evolving with the industry and is in the midst of a transformation to being significantly more customer-centric across its operations, which include cultivation, manufacturing, wholesale and retail business lines. The company operates in one single segment.
52GF Score

Get the complete analysis for VREOD

Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.99
Price
$9.09
GF Value